SCHEMBL7366093

SCHEMBL7366093

O=C(Cc1ccccc1)CC(CCCc1ccccc1)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.59
MMP2 P08253 5/20 0.49
MMP3 P08254 2/20 0.49
MMP1 P03956 1/20 0.49
MMP9 P14780 1/20 0.49
MMP8 P22894 1/20 0.49
CPA1 P15085 3/20 0.47
FOLH1 Q04609 1/20 0.47
TRPA1 O75762 1/20 0.47
CYP1A2 P05177 1/20 0.46
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.45
CPB2 Q96IY4 2/20 0.45
CPB1 P15086 1/20 0.45
CPA3 P15088 1/20 0.45
HDAC3 O15379 1/20 0.44
MAPK1 P28482 1/20 0.44
ADRA1A P35348 1/20 0.44
HDAC4 P56524 1/20 0.44
SLC6A3 Q01959 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8476501 0.90 CPA1 (0.50) GRIK1CPA1CYP1A2CPB2CPB1
SCHEMBL7319632 0.85 GRIK1 (0.64) GRIK1MMP2MMP3CPA1CPB2
SCHEMBL1856639 0.84 GRIK1 (0.72) GRIK1MMP2MMP3MMP1MMP9
SCHEMBL1860416 0.81 GRIK1 (0.68) GRIK1MMP2MMP3MMP1MMP9
SCHEMBL8473749 0.81 TRPA1 (0.54) GRIK1CPA1FOLH1TRPA1CPB2
SCHEMBL7861733 0.81 TSHR (0.66) GRIK1MMP2MMP3MMP1MMP9
SCHEMBL10521966 0.80 FOLH1 (0.72) GRIK1CPA1FOLH1CYP1A2CPB2
SCHEMBL18241165 0.80 GRIK1 (0.66) GRIK1MMP2MMP3MMP1MMP9
SCHEMBL18241164 0.80 GRIK1 (0.66) GRIK1MMP2MMP3MMP1MMP9
SCHEMBL10769990 0.80 FOLH1 (0.72) GRIK1CPA1FOLH1CYP1A2CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1028716-A1 METHOD FOR TREATING AND PREVENTING HEART FAILURE AND VENTRICULAR DILATATION WARNER-LAMBERT COMPANY (US) 2000-08-23 EP disclosed
WO-1998025597-A2 METHOD FOR TREATING AND PREVENTING HEART FAILURE AND VENTRICULAR DILATATION WARNER-LAMBERT COMPANY (US) 1998-06-18 WO disclosed